CN105907394A - Lipid regulating instrument and light source material for lipid regulating instrument - Google Patents
Lipid regulating instrument and light source material for lipid regulating instrument Download PDFInfo
- Publication number
- CN105907394A CN105907394A CN201610389566.7A CN201610389566A CN105907394A CN 105907394 A CN105907394 A CN 105907394A CN 201610389566 A CN201610389566 A CN 201610389566A CN 105907394 A CN105907394 A CN 105907394A
- Authority
- CN
- China
- Prior art keywords
- light source
- fluorophor
- fluorescent
- uprights
- central control
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000463 material Substances 0.000 title claims abstract description 26
- 150000002632 lipids Chemical class 0.000 title claims abstract description 22
- 230000001105 regulatory effect Effects 0.000 title abstract 5
- 239000000126 substance Substances 0.000 claims abstract description 9
- 239000008280 blood Substances 0.000 claims description 26
- 238000000295 emission spectrum Methods 0.000 claims description 12
- 239000000523 sample Substances 0.000 claims description 9
- 239000011575 calcium Substances 0.000 claims description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 3
- 229910052684 Cerium Inorganic materials 0.000 claims description 3
- 229910052692 Dysprosium Inorganic materials 0.000 claims description 3
- 229910052691 Erbium Inorganic materials 0.000 claims description 3
- 229910052689 Holmium Inorganic materials 0.000 claims description 3
- 229910052779 Neodymium Inorganic materials 0.000 claims description 3
- 229910052777 Praseodymium Inorganic materials 0.000 claims description 3
- 229910052772 Samarium Inorganic materials 0.000 claims description 3
- 229910052769 Ytterbium Inorganic materials 0.000 claims description 3
- 229910052788 barium Inorganic materials 0.000 claims description 3
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 claims description 3
- 229910052797 bismuth Inorganic materials 0.000 claims description 3
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 claims description 3
- 229910052791 calcium Inorganic materials 0.000 claims description 3
- GWXLDORMOJMVQZ-UHFFFAOYSA-N cerium Chemical compound [Ce] GWXLDORMOJMVQZ-UHFFFAOYSA-N 0.000 claims description 3
- KBQHZAAAGSGFKK-UHFFFAOYSA-N dysprosium atom Chemical compound [Dy] KBQHZAAAGSGFKK-UHFFFAOYSA-N 0.000 claims description 3
- UYAHIZSMUZPPFV-UHFFFAOYSA-N erbium Chemical compound [Er] UYAHIZSMUZPPFV-UHFFFAOYSA-N 0.000 claims description 3
- KJZYNXUDTRRSPN-UHFFFAOYSA-N holmium atom Chemical compound [Ho] KJZYNXUDTRRSPN-UHFFFAOYSA-N 0.000 claims description 3
- OHSVLFRHMCKCQY-UHFFFAOYSA-N lutetium atom Chemical compound [Lu] OHSVLFRHMCKCQY-UHFFFAOYSA-N 0.000 claims description 3
- QEFYFXOXNSNQGX-UHFFFAOYSA-N neodymium atom Chemical compound [Nd] QEFYFXOXNSNQGX-UHFFFAOYSA-N 0.000 claims description 3
- PUDIUYLPXJFUGB-UHFFFAOYSA-N praseodymium atom Chemical compound [Pr] PUDIUYLPXJFUGB-UHFFFAOYSA-N 0.000 claims description 3
- KZUNJOHGWZRPMI-UHFFFAOYSA-N samarium atom Chemical compound [Sm] KZUNJOHGWZRPMI-UHFFFAOYSA-N 0.000 claims description 3
- 229910052706 scandium Inorganic materials 0.000 claims description 3
- SIXSYDAISGFNSX-UHFFFAOYSA-N scandium atom Chemical compound [Sc] SIXSYDAISGFNSX-UHFFFAOYSA-N 0.000 claims description 3
- 229910052712 strontium Inorganic materials 0.000 claims description 3
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 claims description 3
- NAWDYIZEMPQZHO-UHFFFAOYSA-N ytterbium Chemical compound [Yb] NAWDYIZEMPQZHO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052727 yttrium Inorganic materials 0.000 claims description 3
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 claims description 3
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 2
- 229910052796 boron Inorganic materials 0.000 claims description 2
- 239000011777 magnesium Substances 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- 239000011701 zinc Substances 0.000 claims description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 1
- 239000004020 conductor Substances 0.000 claims 1
- 208000032928 Dyslipidaemia Diseases 0.000 abstract description 9
- 208000017170 Lipid metabolism disease Diseases 0.000 abstract description 9
- 201000010099 disease Diseases 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 3
- 239000000843 powder Substances 0.000 abstract description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 abstract 2
- 230000029918 bioluminescence Effects 0.000 abstract 1
- 238000005415 bioluminescence Methods 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 2
- 238000005842 biochemical reaction Methods 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 208000012239 Developmental disease Diseases 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 1
- 108010021337 lipoprotein triglyceride Proteins 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/067—Radiation therapy using light using laser light
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/64—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing aluminium
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/77—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing rare earth metals
- C09K11/7706—Aluminates
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/77—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing rare earth metals
- C09K11/7712—Borates
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/77—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing rare earth metals
- C09K11/7766—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing rare earth metals containing two or more rare earth metals
- C09K11/778—Borates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0614—Tanning
- A61N2005/0615—Tanning using UV light sources having a specific spectrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0661—Radiation therapy using light characterised by the wavelength of light used ultraviolet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
Abstract
The invention relates to the field of medical treatment, in particular to a lipid regulating instrument and a light source material for the lipid regulating instrument. The light source material comprises fluorescent powder. According to the mass percentage, the fluorescent powder is composed of an ultraviolet phosphor with wavelength of 0.1-100.0% and a visible light phosphor with wavelength of 0.0-99.9%. The ultraviolet fluorescent body is composed of a fluorescent body A or a fluorescent body B or the combination of the fluorescent body A and the fluorescent body B. The chemical expression formula of the fluorescent body A is M1-x-y.Al11O19:CdxRy, and the chemical expression formula of the fluorescent body B is M1-x-y-zLayMgz.B3O7:Pbx. The fluorescent light source which has the advantages of being high in light emitting efficiency, small in luminous decay, high in chemical stability and the like and simulates bioluminescence can be formed, optical irradiation can be adopted for the fluorescent light source and irradiation can be conducted on the humban body according to the biomedical and photonic principles, the fluorescent light source can emit visible light, defocusing laser and healthy waveform of UV-B band, and therefore dyslipidemia and related diseases caused by dyslipidemia can be effectively prevented and treated; the lipid regulating instrument on the basis of the fluorescent light source has the advantages of being simple and compact in structure, convenient to use and remarkable in treatment effect.
Description
Technical field
The present invention relates to field of medical technology, a kind of Adjust-blood lipid instrument and the source material of use thereof.
Background technology
In China, due to the significantly improving of living standard, the reason such as dietary habit changes of the people,
The incidence rate of dyslipidemia is the highest, and in the trend being gradually increasing.Known, dyslipidemia belongs to a class
Relatively conventional disease, is the Developmental and Metabolic Disorder of human body lipoprotein, mainly includes T-CHOL and low-density
The rising of lipoprotein cholesterol, triglyceride and/or high density lipoprotein reduction etc., it is to cause tremulous pulse medicated porridge sample
One of key factor of hardening, is also the independent hazard factor of coronary heart disease and cerebral infarction.
Therefore it provides one can effectively be prevented, treated dyslipidemia and cause because of dyslipidemia relevant
The equipment of disease, has the most real meaning to vast hospitalized patients.
Summary of the invention
The deficiency existed for above-mentioned prior art, one of them purpose of the present invention is a kind of luminous effect
The source material that rate is high, light decay is little, chemical stability is strong；Offer one is provided
Kind simple and compact for structure, based on source material, can effectively prevent, treat dyslipidemia and because of blood
Fat is abnormal and causes the tune fat instrument of relevant disease.
To achieve these goals, the present invention adopts the following technical scheme that
A kind of source material, it includes fluorescent material, and by mass percentage, described fluorescent material is by 0.1-100.0
Ultraviolet light fluorophor and 0.0-99.9 visible fluorescence body constitute, wherein, ultraviolet light fluorophor is by A
Fluorophor constitutes or is made up of B fluorophor or is combined by A fluorophor and B fluorophor；
The chemical expression of described A fluorophor is M1-x-y·Al11O19: CdxRy, the chemistry of described B fluorophor
Expression formula is M1-x-y-zLayMgz·B3O7: Pbx；Wherein, 0.001≤x≤0.1,0.001≤y≤0.5,
0.001≤z≤0.5, M are a kind of element in barium, calcium, magnesium, strontium, zinc or the combination of multiple element, R
For a kind of element or multiple in bismuth, scandium, yttrium, praseodymium, samarium, cerium, dysprosium, holmium, neodymium, erbium, ytterbium, lutecium
The combination of element.
Preferably, described A fluorophor peak of emission spectrum under the exciting of the ultraviolet light that wavelength is 254nm
Value scope is 307 ± 5nm.
Preferably, described B fluorophor peak of emission spectrum under the exciting of the ultraviolet light that wavelength is 254nm
Value scope is 297 ± 5nm.
A kind of Adjust-blood lipid instrument, it includes a vertical body, after the bottom surface of described vertical body extends forward
Be formed with one and step on seat, the top of described vertical body be equiped with one with step on the quantum generator of a parallel distributed,
The middle part of the front side wall of described vertical body, it is equiped with a transmitting between seat and quantum generator stepping on
The peak ranges of spectrum energy-probe between 297-450nm, described quantum generator includes auxiliary
Light source and fluorescence light source, the source material of described fluorescence light source uses above-mentioned a kind of source material, described
Secondary light source is one or more combination in any in daylight lamp, LED, quasiconductor defocused laser lamp.
Preferably, the emission spectrum of described secondary light source is in the range of 610nm-800nm.
Preferably, described fluorescence light source also includes that profile is Straight, elbow-shaped, spheroidal or elliposoidal
Lamp housing, described lamp housing is made up of high-boron-silicon glass.
Preferably, described vertical body includes uprights and is installed in the lower section of rear wall of uprights
Central control desk, described in step on seat and be formed at the bottom front of uprights, described energy-probe is installed in uprights
The middle part of front side wall, be equiped with one in described uprights and by central control desk control and be connected with quantum generator
Lift actuator, described lift actuator drive volume electronic generator relative to uprights make bottom and top feed fortune
Dynamic, described energy-probe and quantum generator electrically connect with central control desk respectively and are controlled by central control desk.
Preferably, step on described in and be equiped with two symmetrical front truckles, described central control desk on the bottom surface of seat
Bottom surface on be equiped with two symmetrical rear truckles and stop in the ground between two rear truckles
Device, described central control desk is also formed with a pushing hands.
Owing to have employed such scheme, the present invention can be formed has that luminous efficiency is high, light decay is little, chemical surely
The qualitative feature such as good also simulates the fluorescence light source of bio-light, and fluorescence light source can use mode that light irradiates the most sharp
Being irradiated human body by biomedical and photonic propulsion principle, source material can be launched visible ray, dissipate
Burnt laser and the healthy waveform of UV-B section；And the Adjust-blood lipid instrument formed based on this source material is discharged
Light quantum by after blood fat selective absorbing, promote the blood fat generation biochemical reaction of human body, utilize human body
Intrinsic blood lipid metabolism approach, cholesterol, triglyceride etc. are by body metabolism, it is thus possible to effectively prevention,
Treatment dyslipidemia and the relevant disease caused therefrom；And it is tight that Adjust-blood lipid instrument has simple in construction
Gather, easy to use, therapeutic effect outstanding feature.
Accompanying drawing explanation
Fig. 1 is the overall structure schematic diagram () of the embodiment of the present invention；
Fig. 2 is the overall structure schematic diagram (two) of the embodiment of the present invention；
Fig. 3 is the STRUCTURE DECOMPOSITION schematic diagram of the embodiment of the present invention；
Fig. 4 is the structural representation of the quantum generator of the embodiment of the present invention.
Detailed description of the invention
Below in conjunction with accompanying drawing, embodiments of the invention are described in detail, but the present invention can be by right
Require that the multitude of different ways limiting and covering is implemented.
A kind of fluorescence light source of the embodiment of the present invention, it includes fluorescent material, by mass percentage, described glimmering
Light powder is made up of the ultraviolet light fluorophor of 0.1-100.0 and the visible fluorescence body of 0.0-99.9, wherein,
Ultraviolet light fluorophor is made up of A fluorophor or is made up of B fluorophor or by A fluorophor and B fluorophor group
Conjunction forms；The chemical expression of A fluorophor is M1-x-y·Al11O19: CdxRy, the chemistry expression of B fluorophor
Formula is M1-x-y-zLayMgz·B3O7: Pbx；Wherein, 0.001≤x≤0.1,0.001≤y≤0.5,0.001
≤ z≤0.5, M are a kind of element in strontium (Sr), calcium (Ca), barium (Ba), zinc (Zn) or multiple unit
Element combination, R be bismuth (Bi), scandium (Sc), yttrium (Y), praseodymium (Pr), samarium (Sm), cerium (Ce), dysprosium (Dy),
A kind of element in holmium (Ho), neodymium (Nd), erbium (Er), ytterbium (Yb), lutecium (Lu) or the combination of multiple element.
Thus, by the improvement of the component of ultraviolet light fluorophor and ultraviolet light being integrally combined with visible ray, can
Forming the fluorescence light source with features such as luminous efficiency are high, light decay is little, chemical stability is good, it can use
Light irradiate mode and utilize the principle of biomedicine and photonic propulsion that human body is irradiated, due to light source material
Material can launch the healthy waveform of visible ray, defocused laser and UV-B section, it is thus possible to effectively prevents, control
Treat dyslipidemia and the relevant disease caused therefrom, to the resistivity and the maintenance that strengthen human body diseases
Health plays vital effect.
For ensureing that fluorescence light source can launch effective healthy waveform, the A fluorophor of the present embodiment is at wavelength
It is preferably 307 ± 5nm for the peak ranges of emission spectrum under the exciting of the ultraviolet light of 254nm.B fluorophor
Under the exciting of the ultraviolet light that wavelength is 254nm, the peak ranges of emission spectrum is then preferably 297 ± 5nm.
Based on above-mentioned fluorescence light source, as shown in Figures 1 to 4, present invention also offers a kind of Adjust-blood lipid instrument
Device, it includes a vertical body, is formed with one and steps on seat 1 after the bottom surface of vertical body extends forward, vertical
The top of formula body be equiped with one with step on the quantum generator 2 of seat 1 parallel distributed, in the front side of vertical body
The middle part of wall, stepping on the peak ranges being equiped with an emission spectrum between seat 1 and quantum generator 2
Energy-probe 3 between 297-450nm, quantum generator 2 includes secondary light source a and fluorescence light source
B, wherein, the source material of fluorescence light source b uses above-mentioned a kind of source material, and secondary light source a is then
For selecting daylight lamp, LED (its Emission Spectrum Peals is 297-800nm) according to concrete condition, partly lead
In body defocused laser lamp (its emission peak is the defocused laser of 650nm) one or more any groups
Close.Thus the biology light source utilizing fluorescence light source b and secondary light source a to constitute Adjust-blood lipid instrument (is i.e. measured
Electronic generator 2), after patient is by stepping on seat 1 and standing on instrument by vertical body, by quantum generator 2
Human body is irradiated, light quantum produced by quantum generator 2 is absorbed by blood fat correspondence, promote
The blood fat generation biochemical reaction of human body, utilizes the metabolism blood fat approach that human body is intrinsic, cholesterol, glycerol three
Ester etc. by body metabolism, with this reach blood fat reducing, blood pressure lowering, fall blood is viscous, improve erythrocyte oxygen carrying capacity,
Blood circulation promoting, improve microcirculation, improve immunity of organisms, strengthen vital capacity, regulation of physiological functions
Etc. purpose；Utilize energy-probe 3 can monitor the light energy being irradiated on human body in real time simultaneously, it is simple to
Intensity of illumination is adjusted in real time.
For ensureing the light radiation response of Adjust-blood lipid instrument, the emission spectrum of the secondary light source a of the present embodiment
Range preferably from 610nm-800nm.
For optimizing the structure of whole Adjust-blood lipid instrument, the fluorescence light source b of the present embodiment also includes that profile is in directly
Tubular, elbow-shaped, spheroidal or the lamp housing (not shown) of elliposoidal, lamp housing is then by high-boron-silicon glass
Make, with this, utilize high boron glass to come through UV-B section light and visible ray and simultaneously to UV-C section light
Line ends, it is ensured that the light transmission of healthy waveform.
For simplifying the structure of whole Adjust-blood lipid instrument to greatest extent, improve its convenience used, this reality
Execute the vertical body of example include uprights 4 and be installed in the central control desk 5 of lower section of rear wall of uprights 4
(its driving plate mainly by shell body, being packaged in shell body and the touch-control behaviour being flush-mounted on shell body
Make screen to constitute), to step on seat 1 and be formed at the bottom front of uprights 4, energy-probe 3 is installed in uprights
The middle part of the front side wall of 4, is equiped with one in uprights 4 simultaneously and is controlled by central control desk 5 and occur with quantum
The lift actuator 6 (it is mainly hydraulically operated the device such as device and guided way and constitutes) that device 2 is connected, rises
Fall driver 6 drive volume electronic generator 2 is made bottom and top feed relative to uprights 4 and is moved, and energy detection
Device 3 and quantum generator 2 electrically connect with central control desk 5 respectively and are controlled by central control desk 5.So, available
Central control desk 5 is as the operation terminal of whole instrument, it is achieved the control to instrumental function, and is driven by lifting
The power that dynamic device 6 is provided, can carry out position adjustment according to the individual instances of patient to quantum generator 2,
Think that patient provides enough standing room, it is simple to human body is irradiated by quantum generator 2.
For strengthening operability and the mobility of instrument, the bottom surface stepping on seat 1 is equiped with two symmetries
The front truckle 7 of distribution, is equiped with two symmetrical rear truckles 8 and on the bottom surface of central control desk 5
(it can make instrument raise to wheel brake 9 between two rear truckles 8, it is ensured that corresponding castor departs from the end
Face, thus prevent instrument from arbitrarily moving), it is also formed with a pushing hands 10 at central control desk 5, it is simple to operation simultaneously
Personnel promote instrument.
For ensureing that Adjust-blood lipid instrument is to the prevention of relevant disease and therapeutic effect, the one of the embodiment of the present invention
Adjust-blood lipid instrument can use method used as described below, and the method comprises the following steps:
S1, actual pathologic condition according to patient, utilize and control assembly and determine the irradiation of quantum generator 2
Time；
S2, after human body stands on instrument, human body is irradiated by utilization electronic generator 2；Wherein,
The light power (i.e. total dose) of quantum generator 2 is that accumulation every day is less than 10 μ w/cm2/ min～
200μw/cm2/ min, the light power (i.e. total dose) of mobile module is that accumulation every day is less than
10μw/cm2/ min～200 μ w/cm2/min。
The foregoing is only the preferred embodiments of the present invention, not thereby limit the scope of the claims of the present invention,
Every equivalent structure utilizing description of the invention and accompanying drawing content to be made or equivalence flow process conversion, or directly
Or indirectly it is used in other relevant technical fields, the most in like manner it is included in the scope of patent protection of the present invention.
Claims (8)
1. a source material, it includes fluorescent material, it is characterised in that: by mass percentage, institute
State fluorescent material to be made up of the ultraviolet light fluorophor of 0.1-100.0 and the visible fluorescence body of 0.0-99.9, its
In, ultraviolet light fluorophor is made up of A fluorophor or is made up of B fluorophor or by A fluorophor and B fluorescence
Body combines；
The chemical expression of described A fluorophor is M1-x-y·Al11O19: CdxRy, the chemistry of described B fluorophor
Expression formula is M1-x-y-zLayMgz·B3O7: Pbx；Wherein, 0.001≤x≤0.1,0.001≤y≤0.5,
0.001≤z≤0.5, M are a kind of element in barium, calcium, magnesium, strontium, zinc or the combination of multiple element, R
For a kind of element or multiple in bismuth, scandium, yttrium, praseodymium, samarium, cerium, dysprosium, holmium, neodymium, erbium, ytterbium, lutecium
The combination of element.
2. a kind of source material as claimed in claim 1, it is characterised in that: described A fluorophor
Under the exciting of the ultraviolet light that wavelength is 254nm, the peak ranges of emission spectrum is 307 ± 5nm.
3. a kind of source material as claimed in claim 1, it is characterised in that: described B fluorophor
Under the exciting of the ultraviolet light that wavelength is 254nm, the peak ranges of emission spectrum is 297 ± 5nm.
4. an Adjust-blood lipid instrument, it is characterised in that: it includes a vertical body, described vertical machine
The bottom surface of body is formed with one and steps on seat after extending forward, the top of described vertical body be equiped with one with step on seat also
The quantum generator of row distribution, the middle part of the front side wall of described vertical body, is positioned at and steps on seat and occur with quantum
The peak ranges of the emission spectrum energy-probe between 297-450nm, institute it is equiped with between device
Stating quantum generator and include secondary light source and fluorescence light source, the source material of described fluorescence light source uses right
Require a kind of source material according to any one of 1-3, described secondary light source be daylight lamp, LED, half
One or more combination in any in conductor defocused laser lamp.
5. a kind of Adjust-blood lipid instrument as claimed in claim 4, it is characterised in that: described fill-in light
The emission spectrum in source is in the range of 610nm-800nm.
6. a kind of Adjust-blood lipid instrument as claimed in claim 4, it is characterised in that: described fluorescence light
Source also includes that profile is the lamp housing of Straight, elbow-shaped, spheroidal or elliposoidal, and described lamp housing is by high boron
Silica glass is made.
7. a kind of Adjust-blood lipid instrument as according to any one of claim 4-6, it is characterised in that:
Described vertical body includes uprights and is installed in the central control desk of lower section of rear wall of uprights, described
Stepping on seat and be formed at the bottom front of uprights, described energy-probe is installed in the front side wall of uprights
Portion, is equiped with one by central control desk control the lift actuator that is connected with quantum generator in described uprights,
Described lift actuator drive volume electronic generator makees bottom and top feed motion relative to uprights, and described energy is visited
Survey device and quantum generator electrically connects with central control desk respectively and is controlled by central control desk.
8. a kind of Adjust-blood lipid instrument as claimed in claim 7, it is characterised in that step on seat described in:
It is equiped with two symmetrical front truckles on bottom surface, the bottom surface of described central control desk is equiped with two symmetries
The rear truckle of distribution and a wheel brake between two rear truckles, described central control desk is also formed with one
Pushing hands.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610389566.7A CN105907394B (en) | 2016-06-03 | 2016-06-03 | A kind of Adjust-blood lipid instrument and its source material used |
| PCT/CN2016/097274 WO2017206380A1 (en) | 2016-06-03 | 2016-08-30 | Lipid regulating instrument and light source material used thereby |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610389566.7A CN105907394B (en) | 2016-06-03 | 2016-06-03 | A kind of Adjust-blood lipid instrument and its source material used |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105907394A true CN105907394A (en) | 2016-08-31 |
| CN105907394B CN105907394B (en) | 2019-01-15 |
Family
ID=56743265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610389566.7A Active CN105907394B (en) | 2016-06-03 | 2016-06-03 | A kind of Adjust-blood lipid instrument and its source material used |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN105907394B (en) |
| WO (1) | WO2017206380A1 (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030075705A1 (en) * | 2001-10-11 | 2003-04-24 | Chien-Yuan Wang | Method for manufacturing white light source |
| CN101508894A (en) * | 2009-03-20 | 2009-08-19 | 孙德春 | Alkaline earth metal borate fluorinate, preparation and uses thereof |
| CN101546688A (en) * | 2009-03-20 | 2009-09-30 | 孙德春 | Fluorescent lamp for poultry and livestock cultivation |
| CN101804247A (en) * | 2010-02-08 | 2010-08-18 | 孙德春 | Animal disease prevention and health care illumination device and use method |
| CN101880531A (en) * | 2010-06-25 | 2010-11-10 | 孙德春 | Rare-earth halophosphate phosphor and prepration method and application thereof |
| CN102597160A (en) * | 2009-10-23 | 2012-07-18 | 默克专利有限公司 | Sm-activated aluminate and borate phosphors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001322867A (en) * | 2000-05-09 | 2001-11-20 | Matsushita Electric Ind Co Ltd | Translucent sintered compact, as fluorescent tube and discharge lamp using the same |
| WO2007055391A1 (en) * | 2005-11-10 | 2007-05-18 | Matsushita Electric Industrial Co., Ltd. | Fluorescent lamp, manufacturing method therefor, lighting device using the fluorescent lamp, and display device |
| JP4971665B2 (en) * | 2006-03-31 | 2012-07-11 | 公立大学法人名古屋市立大学 | Phototherapy device for the treatment of skin diseases |
-
2016
- 2016-06-03 CN CN201610389566.7A patent/CN105907394B/en active Active
- 2016-08-30 WO PCT/CN2016/097274 patent/WO2017206380A1/en active Application Filing
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030075705A1 (en) * | 2001-10-11 | 2003-04-24 | Chien-Yuan Wang | Method for manufacturing white light source |
| CN101508894A (en) * | 2009-03-20 | 2009-08-19 | 孙德春 | Alkaline earth metal borate fluorinate, preparation and uses thereof |
| CN101546688A (en) * | 2009-03-20 | 2009-09-30 | 孙德春 | Fluorescent lamp for poultry and livestock cultivation |
| CN102597160A (en) * | 2009-10-23 | 2012-07-18 | 默克专利有限公司 | Sm-activated aluminate and borate phosphors |
| CN101804247A (en) * | 2010-02-08 | 2010-08-18 | 孙德春 | Animal disease prevention and health care illumination device and use method |
| CN101880531A (en) * | 2010-06-25 | 2010-11-10 | 孙德春 | Rare-earth halophosphate phosphor and prepration method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105907394B (en) | 2019-01-15 |
| WO2017206380A1 (en) | 2017-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3223608U (en) | Killing microorganisms with light using pulsed purple or blue light | |
| KR102465104B1 (en) | Insertion devices and systems for production of emission light inside a medium and methods of using the same | |
| CN101432043A (en) | Light emitting device for use in therapeutic and/or cosmetic treatment | |
| US20040111132A1 (en) | Phototherapeutic treatment methods and apparatus | |
| JP6516219B2 (en) | Photodynamic therapy light irradiator | |
| CA2373594C (en) | Device for the treatment of mucositis | |
| CN1079673A (en) | The High Power LED that is used for photodynamic therapy | |
| KR20180027643A (en) | Quantum Dot Light-Emitting Diodes for Phototherapy | |
| CN101045177A (en) | Phototherapy device | |
| US11913639B2 (en) | Lighting systems for general illumination and disinfection | |
| JP7175437B2 (en) | Apparatus used for radiotherapy | |
| CN106581867A (en) | Intelligent adjusted LED photodynamic therapeutic apparatus | |
| US10709898B2 (en) | Light irradiating device and phototherapy machine | |
| US20230149735A1 (en) | Anti-infective light radiation methods and devices | |
| CN105907394A (en) | Lipid regulating instrument and light source material for lipid regulating instrument | |
| CN105816962B (en) | A kind of diabetes curing instrument and its source material used | |
| US20230045570A1 (en) | Light radiation device for medical treatment | |
| CN106085418B (en) | A kind of gout treatment instrument and its source material used | |
| US20130310902A1 (en) | Apparatus for Maintaining Treatment of Peripheral Neuropathy | |
| CN101862507B (en) | High-power purple-green-red LED light diagnosis and treatment instrument | |
| CN201370897Y (en) | Photodynamic therapy device | |
| CN2675164Y (en) | Photon acne treating apparatus | |
| CN1795944A (en) | Light struck device inuse for treatment of light power | |
| ITTV20100082A1 (en) | EQUIPMENT FOR SKIN TREATMENT |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20200407 Address after: No. 666 super group street, Changchun hi tech Zone, Jilin, Jilin Patentee after: CHANGCHUN XIANYING MEDICAL TECHNOLOGY Co.,Ltd. Address before: Chaoyang District City, Jilin province 130000 Changchun Xinyi Road No. 4 Patentee before: Sun Dechun |
|
| TR01 | Transfer of patent right |